Brief: IQ-AI Ltd Says FDA Grants Orphan Status To Gallium Maltolate For Treating ATRT
Oct 9 (Reuters) - IQ-AI Ltd IQAI.L :
* FDA GRANTS ORPHAN STATUS TO GALLIUM MALTOLATE FOR TREATING
ATRT
Source text for Eikon: ID:nRSI0526Pa
Further company coverage: IQAI.L
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Imaging Biometrics
See all newsImaging Biometrics - US Academic Medical Centre Adopts IB Clinic
Imaging Biometrics - Half Yearly Report to 30 June 2026
Imaging Biometrics - Sub-division
Brief: Imaging Biometrics Says Oral Gallium Maltolate Safe And Well Tolerated Up To 2500 Mg/Day
Brief: Imaging Biometrics Says Expectation Of Progress Towards Profitability In 2026 Is Unchanged